Corporate earnings are playing a key role in uncovering which sectors to invest in, according to one expert. "The past couple of years has been so macro driven - things like the dollar and the Fed - which have really dictated the performance of the equity market," said David Lebovitz, global market strategist at JPMorgan Asset Management. Because of the slow drift higher in stocks in recent years, Lebovitz thinks micro issues are coming back into play. As a result, he's focusing on sectors that are seeing robust bottom line growth and avoiding sectors with no growth, regardless of the reasons. TheStreet's Scott Gamm reports from Wall Street.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.